Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Lockhart CM"'
Publikováno v:
Clinical Ophthalmology, Vol Volume 11, Pp 1897-1901 (2017)
Douglas A Katsev,1 Cailyn C Katsev,1 Jen Pinnow,2 Catherine M Lockhart3 1Santa Barbara Surgery Center, Santa Barbara, CA, 2Pinnow Consulting, Bellingham, WA, 3Omeros Corporation, seattle, WA, USA Purpose: To evaluate the intracameral concentration of
Externí odkaz:
https://doaj.org/article/234bb9dd37354623b517a1c6bfeab085
Autor:
Mai X; Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA., Mendelsohn AB; Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA., Marshall J; Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA., Lin ND; IQVIA, Durham, NC., McDermott CL; AMCP Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA., Ko JS; Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA., Pawloski PA; HealthPartners Institute, Minneapolis, MN., Jamal-Allial A; Carelon, Wilmington, DE., Daniels K; Carelon, Wilmington, DE., McMahill-Walraven CN; CVS Health, Blue Bell, PA., Djibo DA; CVS Health, Blue Bell, PA., Lockhart CM; Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA.; AMCP Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Oct; Vol. 30 (10), pp. 1160-1166.
Autor:
Sullivan SD; CHOICE Institute, School of Pharmacy, University of Washington, Seattle.; Curta, Inc., Seattle, WA., Humphreys SZ; Sutter Health, Sacramento, CA., Fox D; Independent Consultant, Daytona Beach, FL., Lockhart CM; Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA., Tait-Dinger A; Florida Alliance for Healthcare Value, Winter Springs., Betancourt JD; Pfizer, Inc., New York, NY., Komorny KM; Moffitt Cancer Center, Tampa, FL., Haumschild R; Emory Healthcare and Winship Cancer Institute, Atlanta, GA., Chester B; Pfizer, Inc., New York, NY., Harman M; Employers Health, Canton, OH., Roth JA; CHOICE Institute, School of Pharmacy, University of Washington, Seattle.; Pfizer, Inc., New York, NY.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Oct; Vol. 30 (10), pp. 1065-1072. Date of Electronic Publication: 2024 Jul 16.
Autor:
Li KH; University of Washington School of Pharmacy, Seattle., Kaker M; MedImpact, San Diego, CA., Lau J; phactMI, Rutgers University, New Brunswick, NJ., Noonan K; Xcenda, Washington, DC., Zhang S; University of North Carolina Eshelman School of Pharmacy, Chapel Hill., McDermott CL; Biologics and Biosimilars Intelligence Consortium, Alexandria, VA., Lockhart CM; Biologics and Biosimilars Intelligence Consortium, Alexandria, VA.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 May; Vol. 30 (5), pp. 480-489.
Autor:
Gomez-Lumbreras A; Department of Pharmacotherapy, College of Pharmacy, University of Utah, 30S 2000E, Salt Lake City, UT, 84112, USA. Ainhoa.Gomez-Lumbreras@pharm.utah.edu., Ghule P; Department of Pharmacotherapy, College of Pharmacy, University of Utah, 30S 2000E, Salt Lake City, UT, 84112, USA., Panchal R; Department of Pharmacotherapy, College of Pharmacy, University of Utah, 30S 2000E, Salt Lake City, UT, 84112, USA.; University of Utah Health Plans, Murray, UT, USA.; ZS, 2535 West Hillcrest Drive Suite 100, Thousand Oaks, CA, 91320, USA., Giannouchos T; Department of Pharmacotherapy, College of Pharmacy, University of Utah, 30S 2000E, Salt Lake City, UT, 84112, USA.; Department of Health Policy and Organization, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, 35233, USA., Lockhart CM; Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA, USA., Brixner D; Department of Pharmacotherapy, College of Pharmacy, University of Utah, 30S 2000E, Salt Lake City, UT, 84112, USA.
Publikováno v:
International ophthalmology [Int Ophthalmol] 2023 Dec; Vol. 43 (12), pp. 4527-4539. Date of Electronic Publication: 2023 Aug 22.
Autor:
Rai A; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA., Nam YH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA., Mendelsohn AB; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA., Marshall J; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA., McDermott CL; Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA., Toh S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA., Lockhart CM; Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Jul; Vol. 29 (7), pp. 842-847.
Autor:
Lockhart CM; Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA, USA., McDermott CL; Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, VA, USA., Mendelsohn AB; Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA., Marshall J; Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA., McBride A; University of Arizona College of Pharmacy, Tucson, AZ, USA., Yee G; University of Nebraska Medical Center, Omaha, NE, USA., Li MS; University of Tennessee Health Science Center, Memphis, TN, USA., Jamal-Allial A; HealthCore Inc, Wilmington, DE, USA., Djibo DA; CVS Health Clinical Trial Services, Blue Bell, PA, US., Vazquez Benitez G; HealthPartners Institute, Bloomington, MN, USA., DeFor TA; HealthPartners Institute, Bloomington, MN, USA., Pawloski PA; HealthPartners Institute, Bloomington, MN, USA.
Publikováno v:
Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 403-410.
Autor:
Brown JS; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA., Mendelsohn AB; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA., Nam YH; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA., Maro JC; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA., Cocoros NM; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA., Rodriguez-Watson C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, District of Columbia, USA., Lockhart CM; Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, Virginia, USA., Platt R; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA., Ball R; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Dal Pan GJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Toh S; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal of the American Medical Informatics Association : JAMIA [J Am Med Inform Assoc] 2022 Nov 14; Vol. 29 (12), pp. 2191-2200.
Autor:
Pawloski PA; 1HealthPartners Institute, Bloomington, Minnesota., McDermott CL; 2Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, Virginia., Marshall JH; 3Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and., Pindolia V; 4Henry Ford Health System, Detroit, Michigan., Lockhart CM; 2Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, Virginia., Panozzo CA; 3Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and., Brown JS; 3Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and., Eichelberger B; 2Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, Virginia.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2021 Aug 16. Date of Electronic Publication: 2021 Aug 16.
Autor:
Mendelsohn AB; Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA., Marshall J; Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA., McDermott CL; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC), 675 North Washington Street, Suite 220, Alexandria, VA, USA., Pawloski PA; HealthPartners Institute, Minneapolis, MN, USA., Brown JS; Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA., Lockhart CM; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC), 675 North Washington Street, Suite 220, Alexandria, VA, USA. clockhart@bbcic.org.
Publikováno v:
Drugs - real world outcomes [Drugs Real World Outcomes] 2021 Jun; Vol. 8 (2), pp. 125-130. Date of Electronic Publication: 2021 Jan 30.